Praxis Precision Medicines, Inc. (PRAX)
320.55
-7.58
(-2.31%)
USD |
NASDAQ |
Nov 16, 11:33
Praxis Precision Medicines Shareholders Equity (Quarterly) : 1.260B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.260B |
| June 30, 2026 | 1.341B |
| March 31, 2026 | 1.410B |
| December 31, 2025 | 878.14M |
| September 30, 2025 | 343.50M |
| June 30, 2025 | 404.22M |
| March 31, 2025 | 439.21M |
| December 31, 2024 | 445.45M |
| September 30, 2024 | 382.67M |
| June 30, 2024 | 419.10M |
| March 31, 2024 | 229.68M |
| December 31, 2023 | 69.67M |
| September 30, 2023 | 86.76M |
| June 30, 2023 | 105.62M |
| Date | Value |
|---|---|
| March 31, 2023 | 64.47M |
| December 31, 2022 | 76.11M |
| September 30, 2022 | 105.16M |
| June 30, 2022 | 138.87M |
| March 31, 2022 | 191.02M |
| December 31, 2021 | 250.81M |
| September 30, 2021 | 295.92M |
| June 30, 2021 | 333.77M |
| March 31, 2021 | 265.52M |
| December 31, 2020 | 287.46M |
| September 30, 2020 | 108.97M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 40.11M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 6.256B |
| Ironwood Pharmaceuticals, Inc. | -97.19M |
| Xencor, Inc. | 560.44M |
| IDEAYA Biosciences, Inc. | 1.092B |
| ACADIA Pharmaceuticals, Inc. | 1.387B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.312B |
| Total Liabilities (Quarterly) | 52.50M |
| Debt to Equity Ratio | 0.0006 |
| Current Ratio | 14.53 |
| Net Debt Paydown Yield | 0.00% |